Ebrahimi KA, Sabljak P, Simić AP, Skrobić OM, Veličković D, Šljukić V, et al. Significance of KIT and PDGFRA mutations in gastric gastrointestinal stromal tumor imatinib-naive surgically treated patients. Vojnosanit Pregl [Internet]. 2021 Jul. 5 [cited 2026 Jul. 12];76(12). Available from: https://asistent.ceon.rs/index.php/vsp/article/view/16449